Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.17M Sell
445,777
-289,576
-39% -$1.63M 0.04% 498
2026
Q1
$2.21M Hold
735,353
0.02% 567
2025
Q4
$2.57M Sell
735,353
-526,080
-42% -$1.92M 0.03% 562
2025
Q3
$3.83M Sell
1,261,433
-257,366
-17% -$711K 0.04% 513
2025
Q2
$3.9M Buy
1,518,799
+300,000
+25% +$845K 0.04% 504
2025
Q1
$3.06M Buy
1,218,799
+336,703
+38% +$1.24M 0.03% 524
2024
Q4
$2.31M Buy
882,096
+727,905
+472% +$2.56M 0.02% 610
2024
Q3
$589K Sell
154,191
-38,302
-20% -$152K 0.01% 785
2024
Q2
$593K Buy
192,493
+60,482
+46% +$280K 0.01% 777
2024
Q1
$750K Sell
132,011
-255,762
-66% -$1.15M 0.01% 751
2023
Q4
$1.63M Buy
+387,773
New +$720K 0.02% 674

Other funds holding ABSI

Royce & Associates's ABSI Position: Q2 2026 in Review

Royce & Associates reduced its Absci (ABSI) stake by 39% in Q2 2026, selling an estimated $1.63M and leaving 445,777 shares worth $5.17M. The position accounts for 0.04% of the portfolio, ranked #498.

Royce & Associates first reported a position in ABSI in Q4 2023 and has held it in 11 quarters since. 197 funds tracked by Wall St. Rank hold ABSI as of Q2 2026.

  • Royce & Associates held 445,777 shares of Absci worth $5.17M as of Q2 2026.
  • Royce & Associates sold 289,576 Absci shares in Q2 2026, an estimated $1.63M.
  • Absci made up 0.04% of Royce & Associates's portfolio in Q2 2026, its #498 holding.
  • Royce & Associates first reported a position in Absci in Q4 2023 and has held it in 11 quarters since.
  • 197 funds tracked by Wall St. Rank held Absci as of Q2 2026.

Based on Royce & Associates's 13F filing for Q2 2026, filed 14 Aug 2026.